RU2016103088A - Фармацевтическое водорастворимое противогрибковое макромолекулярное соединение - Google Patents
Фармацевтическое водорастворимое противогрибковое макромолекулярное соединение Download PDFInfo
- Publication number
- RU2016103088A RU2016103088A RU2016103088A RU2016103088A RU2016103088A RU 2016103088 A RU2016103088 A RU 2016103088A RU 2016103088 A RU2016103088 A RU 2016103088A RU 2016103088 A RU2016103088 A RU 2016103088A RU 2016103088 A RU2016103088 A RU 2016103088A
- Authority
- RU
- Russia
- Prior art keywords
- polyconjugate
- amino acid
- acid
- macromolecular polymer
- active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310315504 | 2013-07-25 | ||
| CN201310315504.8 | 2013-07-25 | ||
| PCT/CN2014/000146 WO2015010439A1 (zh) | 2013-07-25 | 2014-02-08 | 药用水溶性抗真菌大分子化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2016103088A true RU2016103088A (ru) | 2017-08-30 |
Family
ID=51543906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016103088A RU2016103088A (ru) | 2013-07-25 | 2014-02-08 | Фармацевтическое водорастворимое противогрибковое макромолекулярное соединение |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20160158376A1 (enExample) |
| EP (1) | EP3025733A4 (enExample) |
| JP (1) | JP2016525129A (enExample) |
| KR (1) | KR101749004B1 (enExample) |
| CN (1) | CN104055787B (enExample) |
| AU (1) | AU2014295747B2 (enExample) |
| CA (1) | CA2919145A1 (enExample) |
| HK (1) | HK1220629A1 (enExample) |
| RU (1) | RU2016103088A (enExample) |
| WO (1) | WO2015010439A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110669087B (zh) * | 2018-07-02 | 2023-03-31 | 上海医药工业研究院 | 两性霉素b肽衍生物及其制备方法 |
| CN110577921B (zh) * | 2019-05-28 | 2021-04-02 | 浙江工业大学 | 产两性霉素b的重组结节链霉菌及其应用 |
| CN110343650B (zh) * | 2019-05-28 | 2020-12-29 | 浙江工业大学 | 一种产两性霉素b的重组结节链霉菌及其应用 |
| CN112094362B (zh) * | 2020-09-29 | 2022-04-12 | 四川大学华西医院 | 烟酰胺核糖或单核苷酸类似物-大分子载体轭合物及制法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1359473A (en) | 1970-11-03 | 1974-07-10 | Prodotti Antibiotici Spa | Polyenic antibiotic |
| AU5858690A (en) * | 1989-06-14 | 1991-01-08 | Cetus Corporation | Polymer/antibiotic conjugate |
| US5610264A (en) | 1995-11-16 | 1997-03-11 | Calwood Chemical Industries, Inc. | Continuous process for polyaspartic acid synthesis |
| DE10129369C1 (de) * | 2001-06-21 | 2003-03-06 | Fresenius Kabi De Gmbh | Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats |
| DE10155098A1 (de) * | 2001-11-09 | 2003-05-22 | Supramol Parenteral Colloids | Mittel zur Prävention von mykotischen Kontaminationen bei der Zell- und Gewebekultur bakteriellen, pflanzlichen, animalischen und humanen Ursprungs, bestehend aus Polyen-Makrolid-Konjugaten mit Polysacchariden |
| US7261875B2 (en) * | 2001-12-21 | 2007-08-28 | Board Of Regents, The University Of Texas System | Dendritic poly (amino acid) carriers and methods of use |
| EP1926498A2 (en) * | 2005-09-22 | 2008-06-04 | Hadasit Medical Research Services And Development Company Ltd. | Dextran and arabinogalactan conjugates of therapeutically active compounds |
| US20080181852A1 (en) * | 2007-01-29 | 2008-07-31 | Nitto Denko Corporation | Multi-functional Drug Carriers |
| CN101333044A (zh) * | 2008-05-20 | 2008-12-31 | 北京能拓高科技有限公司 | 箱式组合式污水处理系统 |
| EP2277547A1 (de) * | 2009-07-20 | 2011-01-26 | Merck Patent GmbH | Epsilon-Polylysin-Konjugate und deren Verwendung |
| CN101935336B (zh) * | 2010-09-01 | 2014-04-09 | 北京大学 | 一类水溶性紫杉烷类药物的制备方法和应用 |
| WO2012029827A1 (ja) * | 2010-09-02 | 2012-03-08 | 日本化薬株式会社 | 薬物－ブロックコポリマー複合体とそれを含有する医薬の製造方法 |
| US8785569B2 (en) * | 2011-11-22 | 2014-07-22 | Original Biomedicals Co., Ltd. | Drug carrier with chelating complex micelles and the application thereof |
-
2013
- 2013-12-16 CN CN201310688394.XA patent/CN104055787B/zh not_active Expired - Fee Related
-
2014
- 2014-02-08 HK HK16108769.4A patent/HK1220629A1/en unknown
- 2014-02-08 RU RU2016103088A patent/RU2016103088A/ru unknown
- 2014-02-08 CA CA2919145A patent/CA2919145A1/en not_active Abandoned
- 2014-02-08 WO PCT/CN2014/000146 patent/WO2015010439A1/zh not_active Ceased
- 2014-02-08 US US14/907,555 patent/US20160158376A1/en not_active Abandoned
- 2014-02-08 KR KR1020167001958A patent/KR101749004B1/ko not_active Expired - Fee Related
- 2014-02-08 EP EP14829240.2A patent/EP3025733A4/en not_active Withdrawn
- 2014-02-08 AU AU2014295747A patent/AU2014295747B2/en not_active Ceased
- 2014-02-08 JP JP2016528298A patent/JP2016525129A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014295747A1 (en) | 2016-02-11 |
| WO2015010439A1 (zh) | 2015-01-29 |
| US20160158376A1 (en) | 2016-06-09 |
| KR20160022915A (ko) | 2016-03-02 |
| JP2016525129A (ja) | 2016-08-22 |
| CA2919145A1 (en) | 2015-01-29 |
| EP3025733A1 (en) | 2016-06-01 |
| KR101749004B1 (ko) | 2017-06-19 |
| CN104055787A (zh) | 2014-09-24 |
| AU2014295747B2 (en) | 2016-08-25 |
| CN104055787B (zh) | 2017-04-26 |
| HK1220629A1 (en) | 2017-05-12 |
| EP3025733A4 (en) | 2017-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Du et al. | Polylysine and cysteine functionalized chitosan nanoparticle as an efficient platform for oral delivery of paclitaxel | |
| Zhang et al. | Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel | |
| CN105727309B (zh) | 双敏感两亲性多糖-阿霉素偶联物及其药学组合物的制备和应用 | |
| RU2011130247A (ru) | Способ получения композиции полимерных мицелл, содержащей лекарство, слаборастворимое в воде | |
| EP2431403B1 (en) | Polymer conjugate of bioactive substance having hydroxy group | |
| WO2009066955A3 (en) | Lyophilized pharmaceutical composition with improved stability containing taxane derivatives, and method of manufacturing the same | |
| Mei et al. | Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats | |
| JP2011144207A5 (enExample) | ||
| NZ596610A (en) | A poorly soluble drug containing microsphere with improved bioavailability and method of preparing the same | |
| WO2010039496A3 (en) | Nanocarriers for drug delivery | |
| RU2013114993A (ru) | Композиция каспофунгина | |
| KR20140024833A (ko) | 신규한 시티딘계 대사길항제의 고분자 유도체 | |
| JP2013537212A5 (enExample) | ||
| US9925275B2 (en) | Amphotericin B derivatives | |
| CN102908316B (zh) | 伊维菌素水溶性固体分散体及其制备方法 | |
| Han et al. | Synthesis of a new amphiphilic glycodendrimer with antiviral functionality | |
| Chen et al. | In vitro and in vivo evaluation of PEG-conjugated ketal-based chitosan micelles as pH-sensitive carriers | |
| WO2009066956A3 (en) | Lyophilized pharmaceutical composition with improved reconstitution time containing taxane derivatives and method of manufacturing the same | |
| JP2016525129A5 (enExample) | ||
| US20170080098A1 (en) | Methods of folding a graft copolymer with dual anticancer drugs and related applications | |
| KR101726728B1 (ko) | 고분자 담체 함유 약학 조성물의 유연물질 분석 방법 | |
| Li et al. | Polypeptide-based star-block quadripolymers as unimolecular nanocarriers for the simultaneous encapsulation of hydrophobic and hydrophilic guests | |
| CN105399938B (zh) | 一种两亲性嵌段共聚物及其胶束的制备方法和应用 | |
| KR101749004B1 (ko) | 약학적 수용성 항진균 거대분자 화합물 | |
| Dong et al. | Assessment of the safety, targeting, and distribution characteristics of a novel pH-sensitive hydrogel |